These therapies are constrained to small subsets of patients in the emergency departments of both primary and comprehensive stroke centers; ranging from 10 to 14% of patients for tPA and from 1 to 4% of patients for endovascular clot removal, respectively (Man et al., 2018). Here, PLAT is linked to Stroke.